Glaxosmithkline Pharmaceuticals Ltd logo

GLAXO

Glaxosmithkline Pharmaceuticals Ltd

₹2,735.35

Glaxosmithkline Pharmaceuticals Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹850.29Cr
Net Profits
₹182.33Cr
Net Profit Margins
21.44%

Highlights

Revenue:

Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 4.28% since last year same period to ₹850.29Cr in the Q1 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -11.62% fall in its revenue since last 3-months.

Net Profits:

Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 37.87% since last year same period to ₹182.33Cr in the Q1 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -6.25% fall in its net profits since last 3-months.

Net Profit Margins:

Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 32.21% since last year same period to 21.44% in the Q1 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 6.07% jump in its net profit margins since last 3-months.

FAQs

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2024 was ₹850.29Cr.

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2024 was ₹182.33Cr.

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2024 was 21.44%.

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2023 was ₹815.40Cr.

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2023 was ₹132.25Cr.

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q1 results 2023 was 16.22%.